ETRETINATE AND VISUAL FUNCTION - A 1-YEAR FOLLOW-UP-STUDY

被引：5
|
作者：
PITTS, JF
MACKIE, RM
DUTTON, GN
MCCLURE, EA
ALLAN, D
机构：
[1] UNIV GLASGOW,WESTERN INFIRM,TENNENT INST OPHTHALMOL,38 CHURCH ST,GLASGOW G11 6NT,SCOTLAND
[2] UNIV GLASGOW,WESTERN INFIRM,DEPT DERMATOL,GLASGOW G11 6NT,SCOTLAND
[3] W SCOTLAND HLTH BOARDS,DEPT CLIN PHYS & BIOENGN,GLASGOW G4 9LF,SCOTLAND
来源：
BRITISH JOURNAL OF DERMATOLOGY | 1991年 / 125卷 / 01期
关键词：
D O I：
10.1111/j.1365-2133.1991.tb06039.x
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
Concern has been expressed in the literature that the drug etretinate may be potentially retinotoxic. Four patients are reported who have received long-term treatment with etretinate and who have undergone detailed evaluation for the development of visual dysfunction over a 1-year period. Despite prolonged treatment and high total doses no evidence of ocular toxicity attributable to the drug was found in any of the patients.
引用
收藏
页码：53 / 55
页数：3
相关论文
共 50 条
12345